Albert Bourla

13 results

The vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised. Photograph: iStock

US and European regulators could approve Pfizer and BioNTech’s experimental Covid-19 vaccine as early as mid-December, the German group’s chief execut(...)

Eoin Burke-Kennedy reports on data provided by Minister for Housing Darragh O’Brien showing how much local councils paid for social housing. Photograph: Alan Betson / The Irish Times

Local councils are paying private developers up to double what it costs them on average to build social housing units directly themselves, according t(...)

Pfizer also acknowledged that ‘when it comes to how durable the protection could be, this is something we don’t know yet’. Photograph: Getty

Pfizer chief executive Albert Bourla said a key safety milestone had been reached in the study of its Covid-19 vaccine, and the drug maker is now prep(...)

Albert Bourla: sold 60 per cent of his personal shareholding in Pfizer. Photograph: Bryan Derballa/New York Times

Lucky? Very much so. Legal? Certainly. The sale of 60 per cent of his personal shareholding in the company by Pfizer chief executive Albert Bourla on (...)

The BioNTech-Pfizer shot is in pole position to be first of several potential vaccines under development to receive regulatory approval. Photograph: BioNTech SE 2020/PA Wire

The EU has agreed to buy up to 300 million doses of the groundbreaking coronavirus vaccine developed by BioNTech and Pfizer, following widespread hope(...)

Prof Luke O’Neill, a biochemist at Trinity College Dublin, suggested the data coming from pharmaceutical giant Pfizer is very promising. Photograph: Nick Bradshaw

Epidemiologist Professor Luke O’Neill has said he is confident a vaccine for Covid-19 will be available by the end of the year. Prof O’Neill, a bioc(...)

The Pfizer vaccine is being tested on  38,000 people worldwide. Photograph: Jakub Porzycki/NurPhoto via Getty Images

Pfizer will apply for emergency US approval of the Covid-19 vaccine it is developing with Germany’s BioNTech in the third week of November, the pharma(...)

A pedestrian wearing a protective mask passing in front of a sign outside Pfizer headquarters in New York.

The chief executive of Pfizer has warned about the reputational risks of fast-tracking a Covid-19 vaccine, as governments put pressure on pharmaceutic(...)

The US government has signed a $1.95 billion deal to secure access to 100 million doses of a Covid vaccine being developed by German company BioNTech in association with Pfizer.  Photograph: David Cheskin/PA Wire

The US government has signed a $1.95 billion deal to secure access to 100 million doses of a Covid vaccine being developed by German company BioNTech (...)

Pfizer says it should be able to make millions of doses this year were it to succeed with one of its vaccine candidates

Pfizer has administered the first US patients with its experimental vaccines to fight coronavirus, part of a bid to shave years from the typical time (...)

  • 1
  • 2
  • Next
  • Last »